PM360 2023 Trailblazer Awards Sales Aid Gold Winner Precision Value & Health

Access Genius “Pull-through Solutions” (Precision Value & Health)

Access Genius (AG) combines best-in-class technology and unmatched data synthesis in a smart pharmaceutical market access messaging platform. During its launch period, Access Genius immediately began returning significant results for high-profile drug brands, honing its data-driven algorithm to deliver impactful, HCP-specific pull-through messages. In 2022, Precision Value & Health added two new functionalities to further support market access professionals and sales reps.

The first was Access Genius Insights, which is a pre-call planning tool that combines location-targeted data from multiple data sources to create HCP-specific pre-call strategies. AG Insights better enables strategic conversations by identifying top payers and highest-contributing HCPs, calling out important formulary wins, and showing brands which competitors they need to beat within an HCP’s payer mix.

The other new solution was Access Genius IQ, which trains reps on how to lean into cost and coverage messaging and the best ways to leverage Access Genius with their target HCPs. With real-life scenarios and interactive content, Access Genius IQ teaches reps how to get the most from Access Genius, both in pre-call planning and actual conversations with HCPs. These new Access Genius developments provide brands more ways to leverage data, reach their target HCPs, and deliver effective pull-through, all with the help of one easy-to-use sales tool.

Now, more than 100 brands use Access Genius to streamline their strategies and personalize HCP communications. And as a result, some brands have seen doubled prescribing rates and client reported 4:1 ROI.

Ads

You May Also Like

ELITE 2023 Leader of the Future Ceyda Uslu Güvener of Takeda

Ceyda Uslu Güvener Global Commercial Lead, Plasma Derived Therapies Takeda Unwavering Commitment to Patients ...

PM360 2021 Trailblazer Awards Data/Analytics Initiative Gold Winner EVERSANA

ACTICS by EVERSANA™ (EVERSANA) Rare disease patients spend an average of seven years seeking ...

PM360 2021 Trailblazer Awards Pharma/Biotech Company of the Year Moderna

Moderna has a unique opportunity to make a profound impact on global human health ...